Assessment of and Intention to Use Electronic Health/Patient Records in European Countries
How to cite
Büthe, Tim; Sternberg, Henrike; Munich, Technical University of; Steinert, Janina. 2024. "Assessment of and Intention to Use Electronic Health/Patient Records in European Countries." AEA RCT Registry. AEARCTR-0013737. https://doi.org/10.1257/rct.13737-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
This study seeks to advance our understanding of the general public's overall assessment of — and specifically acceptance of and intention to use – electronic health records (hereafter EHR) in Germany, Italy and the UK, as well as possibly the Netherlands (i.e., what in German is mostly known as the "elektronische Patientenakte", in Italian as the "Fascicolo Sanitario Elettronico" and in English is also known as an electronic medical record). The introduction of this digital health technology holds enormous promise for improvements in individual medical care and population health, including possibly significant cost savings, but take-up of EHRs and similar digital health technologies has been much weaker than public health and medical experts had hoped – in Europe (see, e.g. Albrecht 2016; Albrecht et al 2017; Dahlhausen et al 2022) and beyond (e.g., Dhagarra et al 2020).
We examine patients/citizens' attitudes towards EHRs through the use of an online survey experiment with three alternative information treatments. The survey context allows us to control for (or examine as correlates or in heterogeneity analyses) a variety of pre-treatment factors (health status; experience with, and general attitudes towards, digital goods and services; trust in science, scientists and public authorities; political-ideological preferences; and various demographics) that might be drivers of preferences and acceptance, as well as post-treatment possible broader effects on health policy preferences (including regarding the desirability of various digital health tools (such as digital therapeutics) and interest in using specific features or types of digital health technologies.
Intervention
Preliminary research, including several pilot exploratory studies in Germany pre- and post-pandemic, suggested that there is widespread awareness of some of the possible downsides and risks (esp. concerning privacy and cybersecurity) but rather limited awareness of the benefits and promise of electronic health records. We therefore provide participants with information about some of those benefits as experimental treatments. Specifically, we split our sample into 3 treatment groups and 1 control group. The control group gets just enough basic information to allow the participants assigned to this group to answer questions about electronic health records even if they have never heard or thought about EHRs previously. Each treatment combines the first couple of sentences from the control group's introductory text with a 3-7 line vignette (preceded by a bold heading), which highlights one of the following uses/benefits of having such electronic records:
(i) improved medical treatment in case of accident/emergency
(ii) improved medical care, lower risks/fewer errors for the survey participant
(iii) early detection of population health risks; advances in medical research
The three treatments were selected based on theoretical reasoning leading us to want to examine systematically the distinction between private interests (urgently in treatments i; more broadly in treatment ii) and the public interest (treatments iii), as well as findings from the March 2023 pilot study that none of these benefits are considered widely known (i.e., they should be usable as information treatments). To the extent that the vignettes provide new information to the survey subjects, they also allow us to test more broadly to what extent individual assessments of, e.g., the cost-benefit balance of a digital health technology solutions, is responsive to factual information.
Experimental design
Poor information as an explanation for low levels of technology acceptance is generally frowned upon in much of the social science literature, often to the point of calling into question whether citizens/users' acceptance or refusal/rejection, concerns or skepticisms vis-a-vis technological changes is at all based on a rational assessment of the cost/downside risks and the (expected) benefits. Systematic analyses, however, are comparatively rare, and seem particularly warranted when the information environment is so skewed in favor of downside risks.
Our simple individual-level RCT is designed to test three information treatments (which pilots had shown to be little known among the general population), with random assignment to the treatment arms to allow for causal identification. The experiment is conducted among samples recruited by the survey research firm Respondi/Bilendi such that the sample for each country is representative of the country’s population with respect to gender, age, education, and subnational region.
Just below the information treatment vignette (for respondents in any of the three treatment groups), but before they click "next" to reach the first screen with outcome variables, respondents are asked how well-known they believe the stated benefit of EHRs is among their family members and friends. This question is intended to nudge respondents to engage the substantive contents of the information treatment and seeks to gauge to what extent respondents believe to have already known the information in the vignette, which presumably is inversely correlated with the extent to which the vignette provides new information and thus may be expected to "work" as an information treatment. Answers may therefore also be used in conditional estimates of the treatment effect.
A number of variables drawn from other parts of the survey (such as general attitudes toward technological change or importance of medical care due to, e.g., chronic illness; see abstract, above) will allow us to examine other possible alternative explanations or conditional effects in heterogeneity analyses or robustness checks.
Design details
Cited by
No citation data available for this registration yet.